Philips has announced that DreamStation BiPAP AVAPS devices have been designated as medical necessary for lower-weight patients with breathing impairment.
LivaNova (Nasdaq:LIVN) announced today that it received FDA premarket approval (PMA) for its aura6000 neuromodulation system for sleep apnea.
When you buy through our links, Business Insider may earn an affiliate commission. Learn more Whether you like a gentle, rain-like drizzle or a powerful, high-pressure spray, consider replacing your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results